BIOMAT Database Logo BIOMAT Database Logo

Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy. 1998

R A McClelland, and D L Manning, and J M Gee, and P Willsher, and J F Robertson, and I O Ellis, and R W Blamey, and R I Nicholson
Tenovus Cancer Research Centre, University Hospital of Wales, Heath Park, Cardiff, UK.

Northern hybridization analyses of the oestrogen-inducible mRNAs pLIV1 and pS2 were compared with oestrogen receptor (ER) immunocytochemistry assessments in 40 untreated primary or early recurrent breast tumours. Significant associations were observed between pLIV1/ER (P < 0.03), pS2/ER (P < 0.001) and pLIV1/pS2 (P < 0.04) status. After disease recurrence, patients were treated with assessable courses of endocrine therapies. Positive pLIV1, pS2 and ER statuses in primary disease were consequently found to be predictive of endocrine responsiveness in the secondary lesions (P < 0.03, P < 0.02, P < 0.005 respectively). However, despite these associations, a number of pLIV1- and/or pS2-positive tumours failed to respond to therapy.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009376 Neoplasms, Hormone-Dependent Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment. Hormone-Dependent Neoplasms,Hormone Dependent Neoplasms,Hormone-Dependent Neoplasm,Neoplasm, Hormone-Dependent,Neoplasms, Hormone Dependent
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071163 Trefoil Factor-1 A 60 amino acid (6.5 kDa) trefoil factor that contains a single trefoil domain. It is expressed primarily by surface EPITHELIAL CELLS of the GASTRIC MUCOSA, where it associates with MUCIN 5AC. Protein pS2,TFF1 Peptide,TFF1 Protein,Trefoil Peptide 1,Trefoil Factor 1,pS2, Protein

Related Publications

R A McClelland, and D L Manning, and J M Gee, and P Willsher, and J F Robertson, and I O Ellis, and R W Blamey, and R I Nicholson
Activated oestrogen receptors in breast cancer and response to endocrine therapy.
January 1984, European journal of cancer & clinical oncology,
R A McClelland, and D L Manning, and J M Gee, and P Willsher, and J F Robertson, and I O Ellis, and R W Blamey, and R I Nicholson
Oestrogen receptors and the response to endocrine therapy in advanced breast cancer.
September 1978, British journal of cancer,
R A McClelland, and D L Manning, and J M Gee, and P Willsher, and J F Robertson, and I O Ellis, and R W Blamey, and R I Nicholson
Oestrogen and androgen receptors in breast cancer and response to endocrine therapy.
November 1975, British medical journal,
R A McClelland, and D L Manning, and J M Gee, and P Willsher, and J F Robertson, and I O Ellis, and R W Blamey, and R I Nicholson
Oestrogen receptor in human breast cancer tissue and response to endocrine therapy.
June 1973, British medical journal,
R A McClelland, and D L Manning, and J M Gee, and P Willsher, and J F Robertson, and I O Ellis, and R W Blamey, and R I Nicholson
Oestrogen- and anti-oestrogen-regulated genes in human breast cancer.
January 1995, Ciba Foundation symposium,
R A McClelland, and D L Manning, and J M Gee, and P Willsher, and J F Robertson, and I O Ellis, and R W Blamey, and R I Nicholson
Oestrogen and progesterone receptors and response to endocrine therapy in Japanese breast cancer.
May 1980, Journal of steroid biochemistry,
R A McClelland, and D L Manning, and J M Gee, and P Willsher, and J F Robertson, and I O Ellis, and R W Blamey, and R I Nicholson
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer.
July 2015, Nature communications,
R A McClelland, and D L Manning, and J M Gee, and P Willsher, and J F Robertson, and I O Ellis, and R W Blamey, and R I Nicholson
Breast cancer: a comparison of response to endocrine therapy and oestrogen excretion patterns including unusual metabolites.
November 1981, British journal of cancer,
R A McClelland, and D L Manning, and J M Gee, and P Willsher, and J F Robertson, and I O Ellis, and R W Blamey, and R I Nicholson
Proceedings: Oestrogen receptor activity, plasma oetrogen concentrations and response to endocrine therapy in cancer of the breast.
August 1976, The British journal of surgery,
R A McClelland, and D L Manning, and J M Gee, and P Willsher, and J F Robertson, and I O Ellis, and R W Blamey, and R I Nicholson
Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
September 1983, Clinical oncology,
Copied contents to your clipboard!